Clinical trial

MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I

NCT01501487

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-10-01

PhasePHASE4

Study timeline

Study start (unknown)2011-10-01Date precision: month

Registry last updated2018-06-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

TAC chemotherapyDRUG

TC chemotherapyDRUG

Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemotherapyDRUG

TCH chemotherapyDRUG

T + trastuzumab followed by CEF + trastuzumabDRUG

Dose dense AC followed by T + trastuzumabDRUG

Dose dense AC followed by T + trastuzumab + pertuzumabDRUG

PTH followed by dose dense AC of FECDRUG

Sponsors & collaborators

Agendialead sponsor

University of South Floridacollaborator

University of Miamicollaborator

Morton Plant Mease Health Carecollaborator

AdventHealthcollaborator

Plano Cancer Centercollaborator

Ohio State University Comprehensive Cancer Centercollaborator

University of Oklahomacollaborator

University of South Alabamacollaborator

Mapped research locations

MiamiFlorida, United States1 ColumbusOhio, United States1 TampaFlorida, United States1 Oklahoma CityOklahoma, United States1 The BronxNew York, United States1 ClearwaterFlorida, United States1 MobileAlabama, United States1 PlanoTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01501487 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.